Cyclic Heptapeptide Melanocortin Agonist (MC1R / MC4R) · CAS 189691-06-3
FDA Label Reference (NDA 210557) · Research Vial · MW 1025.16 g/mol (C50H68N14O10 free base) ·PT-141 (Bremelanotide Cyclic Melanocortin Agonist)
Clinical Overview & Worked Dilution Specifications
PT-141 (10mg Vial) — Summary & Reconstitution Math
PT-141 (Bremelanotide, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, C50H68N14O10, CAS 189691-06-3) is a cyclic heptapeptide melanocortin receptor agonist (MC1R/MC4R) whose C-terminal carboxylic acid distinguishes it chemically from Melanotan II. FDA prescribing information for Vyleesi (NDA 210557) documents a ~2.7-hour subcutaneous terminal half-life and ~100% bioavailability for a 1.75 mg intermittent PRN dose (max 1 dose/24h, max 8 doses/month). Reconstituting a 10 mg research vial with 2.0 mL bacteriostatic water yields 5.0 mg/mL (50 mcg/unit on a U-100 syringe; a 1.75 mg aliquot equals 35 Units).
Direct Answer (PT-141 10mg Vial): Reconstituting a 10 mg PT-141 vial with 2 mL of bacteriostatic water produces a 5 mg/mL solution (50 mcg per U-100 unit). For a 1.75 mg (1750 mcg) hypothetical aliquot, draw 35 Units (0.35 mL) on a U-100 syringe (5.71 aliquots/vial; Documented (FDA Label t½ 2.7h) — multi-day accumulation model omitted).
Reference Volumetric Dilution Tiers (No Standardized Clinical Regimen)
Reference Volumetric Dilution Table — PT-141
| Phase | Dose | Volume | U-100 | Doses |
|---|---|---|---|---|
| 0.25 mg | 0.05 mL | 5 u | 40 | |
| 0.5 mg | 0.1 mL | 10 u | 20 | |
| 1 mg | 0.2 mL | 20 u | 10 | |
| 1.75 mg | 0.35 mL | 35 u | 5.7 |
Select any row button to load that target dose into the syringe calculator and half-life simulator.
Syringe Units by Diluent Volume
PT-141 10mg — BAC Water Chart
| Dose | +1 mL BAC10 mg/mL | +1.5 mL BAC6.67 mg/mL | +2 mL BAC5 mg/mL | +3 mL BAC3.33 mg/mL |
|---|---|---|---|---|
| 250 mcg | 2.5 u 0.025 mL | 3.8 u 0.038 mL | 5 u 0.05 mL | 7.5 u 0.075 mL |
| 500 mcg | 5 u 0.05 mL | 7.5 u 0.075 mL | 10 u 0.1 mL | 15 u 0.15 mL |
| 1 mg | 10 u 0.1 mL | 15 u 0.15 mL | 20 u 0.2 mL | 30 u 0.3 mL |
| 1.75 mg | 17.5 u 0.175 mL | 26.3 u 0.263 mL | 35 u 0.35 mL | 52.5 u 0.525 mL |
More BAC water lowers concentration and gives a wider, easier-to-read draw on the syringe barrel.
Volumetric Reference Draw Tiers · Non-Clinical
Documented (FDA Label t½ 2.7h)Reference Volumetric Draw Ladder & Chemical Identity
Pharmacokinetic & Chemical Identity Evidence Boundary
Why Multi-Day Systemic Accumulation Is Omitted (PT-141)
Quick Clinical Reference · 10mg Vial
Common Questions — PT-141 (10mg)
How much bacteriostatic water do I mix with a 10mg PT-141 vial?
Adding 2 mL of bacteriostatic water (0.9% benzyl alcohol) to a 10 mg PT-141 lyophilized vial yields a concentration of 5 mg/mL (50 mcg per U-100 unit). For a hypothetical 1.75 mg (1750 mcg) aliquot, that corresponds to 35 Units (0.35 mL) on a standard U-100 insulin syringe.
How many units on a U-100 syringe is 1.75 mg of PT-141 (10mg vial)?
When a 10 mg PT-141 vial is reconstituted with 2 mL of bacteriostatic water (5 mg/mL), a hypothetical 1.75 mg (1750 mcg) aliquot equals 0.35 mL, or 35 Units on a 100-unit (1.0 mL) U-100 syringe.
How many aliquots are in a 10mg PT-141 vial at 1.75 mg per aliquot?
A 10 mg PT-141 vial provides 5.71 nominal aliquots at 1.75 mg (1750 mcg) per draw (10 mg ÷ 1.75 mg = 5.71). Note that post-reconstitution chemical stability varies by peptide sequence, diluent composition, and storage temperature; always consult compound-specific analytical stability data.
What is the elimination half-life and steady-state timeline of PT-141?
PT-141 (Bremelanotide Cyclic Melanocortin Agonist) (CAS 189691-06-3, MW 1025.16 g/mol (C50H68N14O10 free base)): Human subcutaneous pharmacokinetics are documented in the FDA Vyleesi (bremelanotide injection, NDA 210557, §12.3) prescribing information: following a 1.75 mg subcutaneous dose, median Tmax is ~1.0 hour (range 0.5–1.0 h), absolute subcutaneous bioavailability is ~100%, mean plasma protein binding is 21%, and mean terminal half-life (t½) is approximately 2.7 hours (0.1125 days). Multi-day accumulation simulation is intentionally omitted because bremelanotide is an intermittent as-needed (PRN) agent (maximum 1 dose per 24 hours and ≤8 doses per month due to transient blood pressure elevation and focal hyperpigmentation risk) and the approved autoinjector drug label does not establish bioequivalence for unapproved lyophilized research vials.
How do I convert PT-141 milligrams (mg) or micrograms (mcg) to U-100 syringe units?
Use the three-step dilution formula: (1) Concentration = 10 mg ÷ 2 mL = 5 mg/mL; (2) Volume (mL) = 1.75 mg ÷ 5 mg/mL = 0.35 mL; (3) U-100 Syringe Units = 0.35 mL × 100 = 35 Units.
Peer-Reviewed Primary Literature
Clinical Trials & Analytical References
<iframe src="https://peplab.wiki/compounds/pt-141" width="100%" height="540" style="border:1px solid #e2ddd5;border-radius:12px" loading="lazy"></iframe>
Complete Protocol Index · 25 Reference Peptides & Blends
Switch peptide or multi-compound blend
Affiliate Partner Directory & Independent Lab Verifiers
Documented & Illustrative $/mg Lookup — PT-141 10mg
| Affiliate Partner | COA & Verification Status | Vial Price | $ / Labeled mg | Partner Code | Source, Verifier & Supplier |
|---|---|---|---|---|---|
True Peptides US Fulfillment (UK/EU/CA/AU Shipping Unconfirmed) · Active Affiliate · Documented Catalog Price | Supplier-published 10mg batch COA linked (Lot #260907) — verify current lot on delivery Pricing: Documented 10mg vial ($43.00 catalog price; partner ref peplab) · Pack: 1 vial (10mg lyophilized powder, SKU TP-PT10) · Variant link: Single 10mg SKU on supplier product page (10mg SKU status: In Stock) · Price checked: 2026-11-04 · Report date: 2026-09-22 · Checked: 2026-11-04 · COA PDF (Optiq Health Labs, LLC · COA UID: 1462.OPT.260918-R1 (Sample ID: 1462.OPT.260918)): RP-HPLC Purity (99.2%, spec >=98.0%) + LC-MS Identity Confirmation (PT-141 Bremelanotide; supplier-labeled quantity (10 mg); quantitative content not reported on certificate) | $43.00(10mg catalog SKU) | $4.30/labeled mg | No code needed (Partner Link) | |
Bergdorf Bioscience EU & US Tracked Dispatch (Ships from Germany · $9.99 US / Free ≥$250) · Active Affiliate · Documented Catalog Price | No public batch COA located as of 2026-11-04 — request lot COA from supplier Pricing: Documented 10mg vial ($69.99 standard list / $7.00/mg; $62.99 / $6.30/mg w/ -10% referral code BIO-QTVGWU) · Pack: 1 vial (10mg lyophilized powder) · Variant link: Single 10mg SKU on supplier product page (10mg SKU status: In Stock) · Price checked: 2026-11-06 · Report date: Unlinked · Checked: Unverified | $62.99(w/ referral code; $69.99 standard list · 10mg SKU) | $6.30/labeled mg (w/ code · $7.00/mg list) | ||
Simms Research US Domestic (Tampa, FL · UK/EU/CA/AU Unconfirmed) · Discontinued / Delisted · Historical Catalog Reference | No public batch COA located as of 2026-11-04 — request lot COA from supplier Pricing: Discontinued / Delisted (last checked 2026-11-12): historical 10mg vial ($64.00 standard list / $6.40/mg; $57.60 / $5.76/mg w/ -10% eligible 1st-order code PEPLAB10) · Pack: 1 vial (10mg lyophilized powder) · Variant link: SKU removed / delisted from supplier storefront as of 2026-11-12 — link routes to supplier homepage; compare active in-stock partners above · Price checked: 2026-11-12 · Report date: Unlinked · Checked: Unverified | $57.60(1st order w/ code; $64.00 standard list · 10mg SKU) | $5.76/labeled mg (1st order · $6.40/mg list) |